130 related articles for article (PubMed ID: 33078753)
1. Early death in acute promyelocytic leukemia: Evidence from a rural cancer center.
Golamari KR; Mikkilineni A; Chappidi S
Indian J Cancer; 2020; 57(4):451-456. PubMed ID: 33078753
[TBL] [Abstract][Full Text] [Related]
2. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
3. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience.
Akcay OF; Yeter HH; Buyukasik Y
Rom J Intern Med; 2020 Sep; 58(3):138-145. PubMed ID: 32452194
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in Adult Acute Promyelocytic Leukemia: A Decade Experience.
Yedla RP; Bala SC; Pydi VR; Kuruva SP; Chennamaneni R; Konatam ML; Paul TR; Gundeti S
Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):e158-e164. PubMed ID: 31992504
[TBL] [Abstract][Full Text] [Related]
5. Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.
Lengfelder E; Hanfstein B; Haferlach C; Braess J; Krug U; Spiekermann K; Haferlach T; Kreuzer KA; Serve H; Horst HA; Schnittger S; Aul C; Schultheis B; Erben P; Schneider S; Müller-Tidow C; Wörmann B; Berdel WE; Sauerland C; Heinecke A; Hehlmann R; Hofmann WK; Hiddemann W; Büchner T;
Ann Hematol; 2013 Jan; 92(1):41-52. PubMed ID: 23090499
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of children with acute promyelocytic leukemia treated with Beijing Children's Hospital APL 2005 protocol (BCH-APL 2005).
Zhang Y; Wang L; Zhang R; Qi P; Xie J; Shi H; Lin W; Wu Y; Yu J; Fan J; Feng G; Zheng H; Wu M
Pediatr Hematol Oncol; 2019 Oct; 36(7):399-409. PubMed ID: 31530209
[TBL] [Abstract][Full Text] [Related]
7. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
Chen X; Fan S; Zhao Y; Zhou J
Clin Transl Oncol; 2021 Oct; 23(10):2171-2180. PubMed ID: 33942222
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
9. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
Esteve J; Escoda L; Martín G; Rubio V; Díaz-Mediavilla J; González M; Rivas C; Alvarez C; González San Miguel JD; Brunet S; Tomás JF; Tormo M; Sayas MJ; Sánchez Godoy P; Colomer D; Bolufer P; Sanz MA;
Leukemia; 2007 Mar; 21(3):446-52. PubMed ID: 17205057
[TBL] [Abstract][Full Text] [Related]
11. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
Jillella AP; Kota VK
Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
[TBL] [Abstract][Full Text] [Related]
12. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
[TBL] [Abstract][Full Text] [Related]
13. Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
Tallman MS; Kim HT; Montesinos P; Appelbaum FR; de la Serna J; Bennett JM; Deben G; Bloomfield CD; Gonzalez J; Feusner JH; Gonzalez M; Gallagher R; Miguel JD; Larson RA; Milone G; Paietta E; Rayon C; Rowe JM; Rivas C; Schiffer CA; Vellenga E; Shepherd L; Slack JL; Wiernik PH; Willman CL; Sanz MA
Blood; 2010 Dec; 116(25):5650-9. PubMed ID: 20858857
[TBL] [Abstract][Full Text] [Related]
14. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
Kelaidi C; Chevret S; De Botton S; Raffoux E; Guerci A; Thomas X; Pigneux A; Lamy T; Rigal-Huguet F; Meyer-Monard S; Chevallier P; Maloisel F; Deconinck E; Ferrant A; Fegueux N; Ifrah N; Sanz M; Dombret H; Fenaux P; Adès L
J Clin Oncol; 2009 Jun; 27(16):2668-76. PubMed ID: 19414681
[TBL] [Abstract][Full Text] [Related]
15. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
[TBL] [Abstract][Full Text] [Related]
16. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of data from 73 patients with childhood acute promyelocytic leukaemia receiving modified chemotherapy: a single-centre study.
Zhang ZX; Lu AD; Wu J; Zuo YX; Jia YP; Zhang LP; Qin J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1189-1201. PubMed ID: 33006673
[TBL] [Abstract][Full Text] [Related]
18. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.
Park JH; Qiao B; Panageas KS; Schymura MJ; Jurcic JG; Rosenblat TL; Altman JK; Douer D; Rowe JM; Tallman MS
Blood; 2011 Aug; 118(5):1248-54. PubMed ID: 21653939
[TBL] [Abstract][Full Text] [Related]
19. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide.
Jin B; Zhang Y; Hou W; Cao F; Lu M; Yang H; Tian X; Wang Y; Hou J; Fu J; Li H; Zhou J
J Cancer Res Clin Oncol; 2020 Feb; 146(2):485-492. PubMed ID: 31686248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
